Monday, January 07, 2013 6:04:13 PM
Here's his Bio:
Dr. William Ford Dolphin, Ph.D has been the Chief Executive Officer of Avita Medical Limited since March 05, 2008 and Managing Director since June 2008. Dr. Dolphin served as the Chief Executive Officer and President of SonaMed Corporation. Dr. Dolphin served as the Chief Executive Officer of Visiomed Group Ltd. since February 2005. He served as the President and Chief Technology Officer of a US-based contract research and development company. He also served as the Chairman of the Board, Chief Executive Officer and President of a US medical device company. He served as the Chief Executive Officer of a technology joint venture. He has been a Director at Avita Medical since March 5, 2008. He served as an Executive Director at Visiomed since April 1, 2005. He served as a Director of numerous companies in the US, NZ and Australia. He was Professor in the Departments of Biomedical Engineering and Biology at Boston University. He is the author of more than 60 peer-reviewed scientific articles. He holds 5 US and international patents. He was twice recipient of the National Research Service Award from the National Institutes of Health. Dr. Dolphin holds a PhD in Biophysics from the Boston University in 1989.
For me I place a lot of weight on how much I "like" the CEO, too many crooks and paycheck collectors are running companies, and I am very wary of that. To get personal, at one point I was into studying how to analyze people's behaviors and personality traits. I was building upon my own natural ability to read people. I got very good at it. I like Dolphin, he always presents himself consistently. His IQ seems to be very high, probably in the low 140s and he's full of energy. Most importantly he doesn't lie or BS anyone in the interviews that I've seen, always honest and straightforward. Even when the questions are weak or coming out slow he is respectful and doesn't give the impression that his time is being wasted (so he's not arrogant, important). A genuine person with a genuine belief in the company. Dolphin also makes himself available to shareholders, which is another positive. If you would like his email address I can give it to you.
While I don't know a great deal about this person, I know that Avita hired a big gun for doing sales in China. On the BOD no major league hitters here. But Dolphin seems to very conscientious about spending and as Avita progresses I imagine they'll replace people.
The Chairman Dalton Gooding was a partner at Ernst & Young which should provide some nice connections in the health care industry here in the U.S. Dr. Watt is someone Dolphin brought with him from a previous company he ran. Dr. Fiona Wood non-exec director, she discovered Re-Cell. I get the feeling she is a do-gooder which could be counter productive to real business, but probably a good speaker to the medical field so it's an even break there.
COO -Tim Rooney, I like him, good bit of experience. He was a COO/CFO of a pharmaceutical whole sale company and was there from startup to it being a half billion $ company.
GM Asia Pacific - Lorraine Glover, not much out there about her, she's been with the company for over a decade.
The rest of the management are difficult to find background info on.
Recent RCEL News
- AVITA Medical to Present at 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference • GlobeNewswire Inc. • 09/10/2024 08:03:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/09/2024 02:40:53 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 08/08/2024 11:00:52 PM
- AVITA Medical Reports Second Quarter Financial Results • GlobeNewswire Inc. • 08/08/2024 08:04:00 PM
- AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:11:11 PM
- AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care • GlobeNewswire Inc. • 07/31/2024 08:05:00 PM
- AVITA Medical to Announce Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/11/2024 08:10:00 PM
- AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary • GlobeNewswire Inc. • 07/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 12:48:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:36:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:39:30 PM
- AVITA Medical Achieves Milestone with First Case Using RECELL GO • GlobeNewswire Inc. • 06/05/2024 08:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:34:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:28:05 PM
- AVITA Medical Announces FDA Approval of RECELL GO • GlobeNewswire Inc. • 05/30/2024 01:15:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 05/16/2024 10:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:02:24 PM
- AVITA Medical Reports First Quarter Financial Results • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- AVITA Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/15/2024 09:05:00 PM
- AVITA Medical Updates Expected First Quarter 2024 Revenue • GlobeNewswire Inc. • 04/10/2024 09:11:25 PM
- AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement • GlobeNewswire Inc. • 02/29/2024 09:02:00 PM
- AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 02:00:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM